Bioelectronics innovator NuroKor appoints global expert in pain medicine as new chief medical officer
LEADING innovator in bioelectronic technology NuroKor has welcomed a new addition to its growing team, with the recent appointment of Dr. Ashish Shetty (MBBS, FRCA, FFPMRCA). Dr. Shetty joined as chief medical officer - pain and neuromodulation, bringing with him 10 years’ experience in pain medicine
Dr Ashish Shetty consultant in pain medicine at the National Hospital for Neurology and Neurosurgery, University College London Hospitals, joins NuroKor. Recognised as one of the few medical experts worldwide to specialise in the field, Dr. Shetty has extensive experience in providing various forms of neuromodulation therapy including non-invasive external neuromodulation, peripheral neuromodulation and spinal cord stimulation therapy.
Having previously held positions as clinical research fellow in pain and neuromodulation at Guy’s and St Thomas’ NHS Foundation Trust and honorary consultant at Great Ormond Street Hospital, Dr. Shetty is passionate about the use of neuromodulation for managing complex neuropathic pain conditions including chronic back, leg and pelvic pain. He also has a special interest in headache, abdominal and pelvic pain.
Dr. Shetty continues in his clinical role as consultant in pain medicine at UCLH, where he has practiced for the past seven years, Dr. Shetty joined NuroKor in December and will be responsible for leading the electroceutical development for pain, clinical study and R&D direction, working closely with the scientific team and various stakeholders.
Dr. Shetty’s support will play a vital role in furthering the growth and expansion of NuroKor as it continues to lead in the bioelectronics space.
Speaking about his appointment, Dr. Shetty said:
“Pain is a complicated, often debilitating medical problem that can have a major impact on the physical and mental wellbeing of a person. Every aspect of my work as a consultant, and as NuroKor’s chief medical officer, is driven by the desire to help patients return to independence and have restored quality of life. Neuromodulation therapy is a key component for my patient’s pain management, and the future application of NuroKor’s technology could see multiple medical fields and their patients benefit.”
In addition to his position at NuroKor, Dr. Shetty will continue with his work as UCLH Consultant, and Honorary Associate Professor at UCL.
Rick Rowan, founder and CEO of NuroKor, added: “We are delighted to welcome Dr. Shetty to the NuroKor team. His wealth of knowledge in pain and neuromodulation will be incredibly useful in bolstering the pioneering work we are already doing in the bioelectronics space.
“When it comes to ensuring that our technology is continually evolving in response to patient demands and the latest advancements in pain management, it is crucial that we are working with the very best clinical talent. Harnessing their skills and expertise allows us to keep innovating, and Dr. Shetty’s experience will be invaluable in NuroKor’s bright future.” - Rick Rowan CEO
Founded in 2018, NuroKor is a company committed to the development of bioelectronic technologies. NuroKor develops and formulates programmable bioelectronic software for clinical and therapeutic applications, in a range of easy to use, wearable devices. It provides the highest-quality products, delivering personalised pain relief and recovery support and rehabilitation to patients.